- Home
- MGIC vs RVPHW Comparison
MGIC vs RVPHW Comparison
Compare MGIC & RVPHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGIC
- RVPHW
- Stock Information
- Founded
- MGIC 1983
- RVPHW 2018
- Country
- MGIC Israel
- RVPHW United States
- Employees
- MGIC N/A
- RVPHW 14
- Industry
- MGIC Computer Software: Prepackaged Software
- RVPHW Biotechnology: Pharmaceutical Preparations
- Sector
- MGIC Technology
- RVPHW Health Care
- Exchange
- MGIC Nasdaq
- RVPHW Nasdaq
- Market Cap
- MGIC 990.3M
- RVPHW N/A
- IPO Year
- MGIC 1991
- RVPHW N/A
- Fundamental
- Price
- MGIC $19.39
- RVPHW $0.05
- Analyst Decision
- MGIC Buy
- RVPHW
- Analyst Count
- MGIC 2
- RVPHW 0
- Target Price
- MGIC $18.00
- RVPHW N/A
- AVG Volume (30 Days)
- MGIC 41.9K
- RVPHW 22.4K
- Earning Date
- MGIC 11-17-2025
- RVPHW 03-14-2025
- Dividend Yield
- MGIC 2.91%
- RVPHW N/A
- EPS Growth
- MGIC 16.93
- RVPHW N/A
- EPS
- MGIC 0.78
- RVPHW N/A
- Revenue
- MGIC $584,528,000.00
- RVPHW N/A
- Revenue This Year
- MGIC $11.11
- RVPHW N/A
- Revenue Next Year
- MGIC $6.83
- RVPHW N/A
- P/E Ratio
- MGIC $25.76
- RVPHW N/A
- Revenue Growth
- MGIC 11.98
- RVPHW N/A
- 52 Week Low
- MGIC $10.42
- RVPHW $0.13
- 52 Week High
- MGIC $22.00
- RVPHW $0.15
- Technical
- Relative Strength Index (RSI)
- MGIC 42.26
- RVPHW N/A
- Support Level
- MGIC $19.79
- RVPHW N/A
- Resistance Level
- MGIC $20.80
- RVPHW N/A
- Average True Range (ATR)
- MGIC 0.50
- RVPHW 0.00
- MACD
- MGIC -0.03
- RVPHW 0.00
- Stochastic Oscillator
- MGIC 31.46
- RVPHW 0.00
About MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.